July 3 (Reuters) - Jazz Pharmaceuticals Plc:
* Jazz Pharmaceuticals says on June 28, its unit entered into a pharmacy master services agreement with express scripts specialty distribution services
* Says under master services agreement, jazz is billed monthly for services performed by express scripts
* Jazz Pharmaceuticals - pursuant to agreement express scripts provides exclusive distribution and other services to jazz related to sale and marketing of xyrem oral solution in u.s.
* Jazz Pharmaceuticals plc - master services agreement will expire on June 30, 2019, subject to a one-year extension at option of jazz Source text (bit.ly/2skaHR9) Further company coverage: